To this purpose, IBD and psoriatic patients, treated with anti-TNF-α drugs and characterized for the main clinical–pathologic characteristics, were genotyped at six single nucleotide polymorphisms (SNPs) selected for their possible role in the susceptibility to classical and paradoxical psoriasis and in the response to anti-TNF-α drugs. This evidence concerns the gene TNF and psoriasis.